Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 12631 | Nucleus (India) | 4.4 | Q3 | Springer Nature | 46.0% 186/348 Genetics | 681 | 155 |
| 12632 | Cold Spring Harbor Molecular Case Studies | 4 | Q3 | Cold Spring Harbor Laboratory Press | 44.0% 56/100 Genetics (clinical) | 656 | 164 |
| 12633 | Current Molecular Medicine | 4.8 | Q3 | Bentham Science Publishers | 44.0% 246/441 Biochemistry | 1602 | 335 |
| 12634 | Extremophiles | 4.6 | Q3 | Springer Nature | 44.0% 104/188 Microbiology | 721 | 156 |
| 12635 | SAR and QSAR in Environmental Research | 4.2 | Q3 | Taylor & Francis | 43.0% 89/156 Drug Discovery | 836 | 201 |
| 12636 | Central Nervous System Agents in Medicinal Chemistry | 2.6 | Q3 | Bentham Science Publishers | 42.0% 45/77 Neuropsychology and Physiological Psychology | 187 | 72 |
| 12637 | Viral Immunology | 3.6 | Q3 | Mary Ann Liebert | 41.0% 51/86 Virology | 974 | 271 |
| 12638 | Journal of Peptide Science | 3.6 | Q3 | John Wiley & Sons | 41.0% 188/321 Pharmacology | 930 | 255 |
| 12639 | Acta Naturae | 3.4 | Q3 | Acta Naturae | 41.0% 185/314 Biotechnology | 584 | 174 |
| 12640 | Infectious Disorders - Drug Targets | 3.3 | Q3 | Bentham Science Publishers | 40.0% 88/148 Microbiology (medical) | 1114 | 342 |
| 12641 | Letters in Drug Design and Discovery | 1.8 | Q3 | KeAi Communications Co. | 39.0% 113/185 Pharmaceutical Science | 1081 | 610 |
| 12642 | Pharmacogenomics | 3.3 | Q3 | Taylor & Francis | 38.0% 197/321 Pharmacology | 1112 | 338 |
| 12643 | Current Pharmaceutical Analysis | 1.7 | Q3 | KeAi Communications Co. | 38.0% 115/185 Pharmaceutical Science | 494 | 291 |
| 12644 | Tropical Journal of Natural Product Research | 1.6 | Q3 | Faculty of Pharmacy, University of Benin | 37.0% 116/185 Pharmaceutical Science | 2537 | 1584 |
| 12645 | Assay and Drug Development Technologies | 3.3 | Q3 | Mary Ann Liebert | 34.0% 103/156 Drug Discovery | 448 | 134 |
| 12646 | International Journal of Molecular and Cellular Medicine | 2.4 | Q3 | Babol University of Medical Sciences | 33.0% 210/314 Biotechnology | 277 | 117 |
| 12647 | Cardiovascular and Hematological Disorders - Drug Targets | 1.8 | Q3 | Bentham Science Publishers | 32.0% 268/397 Cardiology and Cardiovascular Medicine | 197 | 112 |
| 12648 | Yaoxue Xuebao | 1.1 | Q3 | Chinese Pharmaceutical Association | 31.0% 53/77 General Pharmacology, Toxicology and Pharmaceutics | 1730 | 1520 |
| 12649 | Current Computer-Aided Drug Design | 3 | Q3 | Bentham Science Publishers | 30.0% 109/156 Drug Discovery | 730 | 240 |
| 12650 | Expert Review of Precision Medicine and Drug Development | 2.3 | Q3 | Taylor & Francis | 29.0% 227/321 Pharmacology | 116 | 50 |
| 12651 | Turkish Computational and Theoretical Chemistry | 1.4 | Q3 | DergiPark | 26.0% 92/125 Biochemistry, Genetics and Molecular Biology (miscellaneous) | 92 | 68 |
| 12652 | Clinical and Experimental Morphology | 1 | Q4 | MDV Group | 23.0% 156/204 Pathology and Forensic Medicine | 136 | 139 |
| 12653 | Current Cancer Therapy Reviews | 1 | Q4 | Bentham Science Publishers | 22.0% 322/415 Oncology | 121 | 124 |
| 12654 | Nucleosides, Nucleotides and Nucleic Acids | 2.1 | Q4 | Taylor & Francis | 20.0% 351/441 Biochemistry | 659 | 308 |
| 12655 | Cellular Therapy and Transplantation | 0.5 | Q4 | Universitatsklinikum Hamburg - Eppendorf | 17.0% 46/55 Transplantation | 60 | 118 |
| 12656 | Current Enzyme Inhibition | 1.3 | Q4 | Bentham Science Publishers | 13.0% 381/441 Biochemistry | 110 | 82 |
| 12657 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | 1 | Q4 | Pleiades Publishing | 9.0% 398/441 Biochemistry | 145 | 142 |
| 12658 | VacciMonitor | 0.4 | Q4 | Finlay Ediciones | 6.0% 217/231 Immunology and Allergy | 27 | 61 |
| 12659 | OBM Genetics | 0.7 | Q4 | LIDSEN Publishing Inc | 4.0% 392/410 Molecular Biology | 93 | 142 |
| 12660 | Chinese Journal of Cancer Biotherapy | 0.2 | Q4 | Editorial office of Chinese Journal of Cancer Biotherapy | 4.0% 308/321 Pharmacology | 84 | 503 |